Start |Forschung|Abteilungen / AGs / Institute|Abhängiges Verhalten und Suchtmedizin|Arbeitsgruppen|AG Neuroenhancement|Publikationen

Publikationen: Neuroenhancement

Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register Study. Acta Psychiatr Scand. 2025 152(2):94-103. Epub 2025 Mar 17.
Türkmen C, Machunze N, Lee AM, Bougelet E, Ludin NM, de Cates AN, Vollstädt-Klein S, Bach P, Kiefer F, Andreas JB, Kamphuis J, Schoevers RA, Emslie GJ, Hetrick SE, Viechtbauer W, van Dalfsen JH. Systematic Review and Meta-Analysis: The Association Between Newer Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2025 64(10):1148-1164. Epub 2025 Jan 17.
Wazulin L, Jamin M, Andone I, Blaszkiewicz K, Reinhard I, Eibes M, Christian Wolf R, Kasem Q, Markowetz A, Leménager T, Bach P. Investigation of smartphone use characteristics underlying problematic smartphone use by dense longitudinal smartphone tracking. Comput Hum Behav. 2025 173:108766.
Zaiser J, Hoffmann S, Zimmermann S, Gessner T, Deck M, Bekier N, Abel M, Radler P, Langejürgen J, Lenz B, Vollstädt-Klein S, Stallkamp J, Kirschbaum C, Kiefer F, Bach P. Individual stress reactivity predicts alcohol craving and alcohol consumption in alcohol use disorder in experimental and real-life settings. Transl Psychiatry. 2025 15(1):226.
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de